LEP and adenocarcinoma: Among the 286 patients, 51 (17.8%) were LEP-predominant, 178 (62.2%) were ACI-predominant, 16 (5.6%) were PAP-predominant, 29 (10.1%) were MIP-predominant, and 12 (4.2%) were SOL-predominant adenocarcinoma.